Common Stock ($0.001 par value) Underwriting AgreementUnderwriting Agreement • October 5th, 2010 • Oragenics Inc • Pharmaceutical preparations • New York
Introductory. Oragenics, Inc., a Florida corporation (the “Company”), proposes to issue and sell (the “Offering”) to the several underwriters named in Schedule I (the “Underwriters”), for whom ThinkEquity LLC is acting as representative (the “Representative”), an aggregate of _________ shares (the “Underwritten Securities”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”). The Company also proposes to issue and sell at the Underwriters’ option, solely to cover over-allotments, an aggregate of up to _________ additional shares of Common Stock (the “Option Securities”, and together with the Underwritten Securities, the “Securities”) as set forth below.
